These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24938581)

  • 1. Editorial comment.
    Ganpule AP; Desai M
    Urology; 2014 Aug; 84(2):419-20. PubMed ID: 24938581
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: To PMID 24938580.
    Pinggera GM
    Urology; 2014 Aug; 84(2):420. PubMed ID: 24938582
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Effect of tadalafil once daily on prostate blood flow and perfusion in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, double-blind, multicenter, placebo-controlled trial.
    Kaplan SA
    J Urol; 2015 May; 193(5):1592-3. PubMed ID: 25895781
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of tadalafil once daily on prostate blood flow and perfusion in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, double-blind, multicenter, placebo-controlled trial.
    Pinggera GM; Frauscher F; Paduch DA; Bolyakov A; Efros M; Kaminetsky J; Da Pozzo L; Esler A; Cox D
    Urology; 2014 Aug; 84(2):412-9. PubMed ID: 24938580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial comment to Tadalafil 5 mg once-daily therapy for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results from a randomized, double-blind, placebo-controlled trial carried out in Japan and Korea.
    Akino H
    Int J Urol; 2014 Jul; 21(7):676. PubMed ID: 24588836
    [No Abstract]   [Full Text] [Related]  

  • 6. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
    Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
    J Urol; 2013 Jan; 189(1 Suppl):S135-40. PubMed ID: 23234619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tadalafil once daily on maximum urinary flow rate in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Roehrborn CG; Chapple C; Oelke M; Cox D; Esler A; Viktrup L
    J Urol; 2014 Apr; 191(4):1045-50. PubMed ID: 24445278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to onset of clinically meaningful improvement with tadalafil 5 mg once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: analysis of data pooled from 4 pivotal, double-blind, placebo controlled studies.
    Oelke M; Shinghal R; Sontag A; Baygani SK; Donatucci CF
    J Urol; 2015 May; 193(5):1581-9. PubMed ID: 25437533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Hartmut Porst, Edward D. Kim, Adolfo R. Casabé, et al., for the LVHJ study team. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial. Eur Urol 2011;60:1105-13.
    Serefoglu EC; Mitchell GC; Hellstrom WJ
    Eur Urol; 2012 May; 61(5):e45-6; author reply e47-8. PubMed ID: 22342774
    [No Abstract]   [Full Text] [Related]  

  • 10. Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.
    Brock G; Broderick G; Roehrborn CG; Xu L; Wong D; Viktrup L
    BJU Int; 2013 Nov; 112(7):990-7. PubMed ID: 23937669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.
    Porst H; Kim ED; Casabé AR; Mirone V; Secrest RJ; Xu L; Sundin DP; Viktrup L;
    Eur Urol; 2011 Nov; 60(5):1105-13. PubMed ID: 21871706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial Comment to tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.
    Gacci M
    Int J Urol; 2013 Feb; 20(2):202. PubMed ID: 22958135
    [No Abstract]   [Full Text] [Related]  

  • 13. Tadalafil - a therapeutic option in the management of BPH-LUTS.
    Carson CC; Rosenberg M; Kissel J; Wong DG
    Int J Clin Pract; 2014 Jan; 68(1):94-103. PubMed ID: 24341303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of once-daily tadalafil in men with signs and symptoms of benign prostatic hyperplasia on concomitant α1-adrenergic antagonist therapy: results of a multicenter randomized, double-blind, placebo-controlled trial.
    Goldfischer E; Kowalczyk JJ; Clark WR; Brady E; Shane MA; Dgetluck N; Klise SR
    Urology; 2012 Apr; 79(4):875-82. PubMed ID: 22341603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.
    Yokoyama O; Yoshida M; Kim SC; Wang CJ; Imaoka T; Morisaki Y; Viktrup L
    Int J Urol; 2013 Feb; 20(2):193-201. PubMed ID: 22958078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a single treatment with tadalafil on blood flow in lower urinary tract tissues in rat models of bladder overdistension/emptying and abdominal aorta clamping/release.
    Yoshinaga R; Kawai Y; Oka M; Fuchikami C; Oyama T
    Eur J Pharmacol; 2015 May; 754():92-7. PubMed ID: 25697472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of daily 5 mg tadalafil improves endothelial function in patients with benign prostatic hyperplasia.
    Amano T; Earle C; Imao T; Matsumoto Y; Kishikage T
    Aging Male; 2018 Mar; 21(1):77-82. PubMed ID: 28830281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Proportion of Tadalafil-Treated Patients with Clinically Meaningful Improvement in Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia-Integrated Data from 1,499 Study Participants.
    Kaplan SA
    J Urol; 2016 Feb; 195(2):426. PubMed ID: 26853001
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in asian men.
    Kaplan SA
    J Urol; 2014 May; 191(5):1345. PubMed ID: 24745512
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
    Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
    J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.